Last SFr.93.48 CHF
Change Today +0.45 / 0.48%
Volume 110.0K
NOVNEE On Other Exchanges
SIX Swiss Ex
New York
SIX Swiss Ex
As of 11:05 AM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David R. Epstein B.Sc., M.B.A.

Division Head of Novartis Pharmaceuticals and Member of Executive Committee, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 6 different industries.

As of Fiscal Year 2013


Mr. David R. Epstein, B.Sc., M.B.A. serves as Division Head of Novartis Pharmaceuticals at Novartis AG. Mr. Epstein serves as President of Novartis at Novartis Pharma K.K. He has been Head of Global Pharmaceuticals Division at Novartis AG and Novartis Vaccines and Diagnostics, Inc. since February 1, 2010. Mr. Epstein serves as President and Chief Executive Officer of Oncology and Molecular Diagnostics of Novartis Institutes for Biomedical Research, Inc. He served as ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056


Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

Former Independent Director, Member of Governance & Nominating Committee and Member of Research, Regulatory & Clinical Committee


MBA 1987
Columbia Business School
BS 1984
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,979,600

Stock Options*

Restricted Stock Awards$6,887,751
All Other Compensation$405,092

Total Compensation*

Total Annual Cash Compensation$2,384,692
Total Short Term Compensation$1,979,600
Other Long Term Compensation$7,292,843
Total Calculated Compensation$9,272,443
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVNEE:SW SFr.93.48 CHF +0.45


John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-2ND LINE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at